Because of the MCM2–7 complex has a critical function in DNA replication and oncogenic signaling pathways, we aimed to study whether MCM2–7 expression may potentially be used to predict the prognosis of patients with nasopharyngeal cancer treated with definitive radiotherapy as well as potential therapeutic targets for anticancer treatments. This evidence concerns the gene MCM2 and nasopharyngeal carcinoma.